Pharmigene Market Cap

Pharmigene has a market cap or net worth of 499.60 million as of April 28, 2026. Its market cap has decreased by -30.04% in one year.

Market Cap

499.60M

Enterprise Value

1.04B

Revenue

149.25M

Ranking

n/a

PE Ratio

n/a

Stock Price

10.00

Market Cap Chart

Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 499.60M, a decrease of -53.84%. That is a compound annual growth rate of -13.45%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	499.60M	-
Dec 31, 2025	499.60M	-30.53%
Dec 31, 2024	719.13M	-31.16%
Dec 29, 2023	1.04B	21.08%
Dec 30, 2022	862.78M	-8.53%
Dec 30, 2021	943.19M	-13.20%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Welgene Biotech	427.63M
Sofiva Genomics	708.26M
TFBS Bioscience	726.73M
Puriblood Medical	735.69M
Kim Forest Enterprise	772.96M
Genetics Generation Advancement	1.16B
DIVA Laboratories	1.82B
BIONET	3.75B

Market Cap Rankings